Lydon Nicholas 4
4 · Blueprint Medicines Corp · Filed Sep 21, 2020
Insider Transaction Report
Form 4
Lydon Nicholas
Director
Transactions
- Sale
Common Stock
2020-09-17$80.00/sh−500$40,000→ 47,240 total
Footnotes (1)
- [F1]Effected pursuant to a trading plan adopted on February 27, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.